Edition:
United States

T2 Biosystems Inc (TTOO.OQ)

TTOO.OQ on NASDAQ Stock Exchange Global Market

3.22USD
26 May 2017
Change (% chg)

$0.07 (+2.22%)
Prev Close
$3.15
Open
$3.21
Day's High
$3.28
Day's Low
$3.15
Volume
12,332
Avg. Vol
17,487
52-wk High
$9.49
52-wk Low
$3.02

Latest Key Developments (Source: Significant Developments)

T2 Biosystems reports Q1 revenue $941,000
Tuesday, 2 May 2017 04:01pm EDT 

May 2 (Reuters) - T2 Biosystems Inc :T2 Biosystems reports first quarter 2017 results and corporate update.Q1 loss per share $0.48.Q1 revenue $941,000.Sees Q2 revenue $100,000.Q1 revenue view $2 million -- Thomson Reuters I/B/E/S.Q1 earnings per share view $-0.46 -- Thomson Reuters I/B/E/S.T2 Biosystems Inc- Company anticipates total operating expenses for Q2 of 2017 to be between $12.3 million and $12.9 million.T2 Biosystems Inc- Company anticipates continued growth of product revenue in Q2 of 2017 from an increase in T2candida panel sales.  Full Article

T2 Biosystems reports qtrly loss per share of $0.48
Tuesday, 2 May 2017 04:01pm EDT 

May 2 (Reuters) - T2 Biosystems Inc ::T2 biosystems reports first quarter 2017 results and corporate update.Sees Q2 research revenue to be below $100,000 .Q1 loss per share $0.48.Q1 revenue $941,000.Q1 revenue view $2 million -- Thomson Reuters I/B/E/S.Q1 earnings per share view $-0.46 -- Thomson Reuters I/B/E/S.Company anticipates total operating expenses for Q2 of 2017 to be between $12.3 million and $12.9 million.Company anticipates continued growth of product revenue in Q2 of 2017 from an increase in T2Candida panel sales.  Full Article

T2 Biosystems names Darlene Deptula-Hicks as CFO
Monday, 1 May 2017 09:00am EDT 

May 1 (Reuters) - T2 Biosystems Inc : :T2 Biosystems names Darlene Deptula-Hicks as chief financial officer.Deptula-Hicks was most recently CFO and senior vice president at Pieris Pharmaceuticals Inc.T2 Biosystems Inc - Deptula-Hicks was most recently CFO and senior vice president at Pieris Pharmaceuticals Inc.  Full Article

T2 Biosystems files for resale of up to 6.06 mln shares by selling stockholder
Monday, 20 Mar 2017 04:08pm EDT 

T2 Biosystems Inc :T2 biosystems inc - files for resale of up to 6.06 million shares of co's common stock, par value $0.001 per share, by selling stockholder.  Full Article

T2 Biosystems qtrly loss per share $0.48
Wednesday, 8 Mar 2017 04:57pm EST 

T2 Biosystems Inc : Qtrly loss per share $0.48 . T2 Biosystems Inc - on March 2, Shawn Lynch notified company of his resignation from his position as company's CFO effective immediately . T2 Biosystems Inc - Lynch indicated that he resigned for personal reasons .Qtrly total revenue $910,000 versus $1 million.  Full Article

T2 Biosystems reports Q4 revenue $910,000
Monday, 13 Feb 2017 04:01pm EST 

T2 Biosystems Inc : T2 Biosystems reports fourth quarter and full-year 2016 results . Q4 revenue $910,000 . Q4 revenue view $1.4 million -- Thomson Reuters I/B/E/S .T2 Biosystems - sees higher product revenue in Q1 2017 from an increase in T2Candida panel sales due to increased patient testing across installed base.  Full Article

T2 Biosystems says reports preliminary Q4 results
Monday, 9 Jan 2017 06:30am EST 

T2 Biosystems Inc : T2 biosystems reports preliminary fourth quarter results and operational progress . T2 biosystems reports preliminary fourth quarter results and operational progress .Sees estimated preliminary product revenue indicates year-over-year growth by over 50 percent compared to 2015 q4.  Full Article

Japan's Canon Inc reports 19.9 pct stake in T2 Biosystems - SEC filing
Friday, 30 Sep 2016 06:29am EDT 

T2 Biosystems Inc : Japan's Canon Inc reports 19.9 pct stake in T2 Biosystems Inc as of September 21, 2016 - SEC filing . Canon says T2 Biosystems and Canon USA entered into a voting and standstill agreement and a registration rights agreement . Canon says T2 Biosystems has agreed to give Canon USA certain board designation rights . Canon says T2 Biosystems to initially appoint Seymour Liebman, an EVP at Canon USA, as a class I director on the T2 board .Canon says Canon USA beneficially owns 6 million shares of common stock of T2 Biosystems as of Sept 21.  Full Article

T2 biosystems says it has sold $39.7 million in equity financing
Tuesday, 27 Sep 2016 04:51pm EDT 

T2 Biosystems Inc :Says it has sold $39.7 million in equity financing - SEC filing.  Full Article

Canon U.S.A. announces equity investment in T2 Biosystems
Thursday, 22 Sep 2016 09:26am EDT 

Canon U.S.A. <7751.T> : Canon U.S.A. announces equity investment in T2 Biosystems Inc . Has purchased approximately $40 million of T2 biosystems stock at closing market price of $6.56 in a private placement . Says investment results in Canon's ownership of approximately 19.9 percent of T2 Biosystems .Seymour Liebman , EVP, chief administrative officer and general counsel, Canon U.S.A Inc will join T2 Biosystems board of directors.  Full Article

More From Around the Web

BRIEF-T2 Biosystems names Darlene Deptula-Hicks as CFO

* T2 Biosystems names Darlene Deptula-Hicks as chief financial officer